AbstractIntroduction-Enterococci are part of the normal intestinal flora of humans and animals but have also emerged as important pathogens responsible for serious infections in hospital and community acquired infections. According to recent surveys, Enterococci remain in the top 3 most common pathogens that cause nosocomial infections. Aim-To process all the clinical samples from various departments in our hospital, for the isolation of Enterococci sp. To speciate the isolates & to have the resistance pattern of the isolates to Vancomycin Methods and Material-A total of 928 samples were collected from both out patients and in patients in all clinical departments and transported to microbiology laboratory. Specimens were processed by inoculating on to Mac Conkeys agar, blood agar, nutrient agar and Pfizer selective media and incubated at 37 0 C for 24 -48 hours. Enterococci were identified by their typical arrangement in Gram stain, Bile esculin test and salt tolerance test. Speciation was done by subjecting the isolates to a battery of biochemical tests. Antimicrobial susceptibility patterns were determined by performing Kirby-Bauer disc diffusion method and Minimum Inhibitory Concentration (MIC) values were identified by Tube & Agar dilution method. Results-A total of 928 samples. Among these, 647 (69.72%) were culture positive with different isolates and 281 (30.28%) were culture negative. Among 647 culture positive cases, 100 (15.46%) were Enterococcus faecalis. Antimicrobial susceptibility & MIC done as per standard protocols. The E. Faecalis showed 99% sensitive to Vancomycin. The resistance to Vancomycin was further confirmed by MIC both Agar &Tube dilution methods, in which the MIC was: 32µg/ml in one isolate. Conclusions-Species level identification of Enterococcus is not only important for epidemiological study, but also for analysing the drug resistant pattern. Effective detection of Vancomycin resistance in laboratory helps in reducing the morbidity and mortality due to VRE in hospitalized patients.
Introduction
Enterococci are part of the normal intestinal flora of humans and animals but have also emerged as important pathogens responsible for serious infections in hospital and community acquired infections. The genus Enterococcus includes more than 17 species, but only a few cause clinical infections in humans [1] .
Enterococci were originally classified as enteric gram-positive cocci and later included in the genus Streptococcus. In the 1930s, with the establishment of the Lancefield serological typing system, Enterococci were classified as group D streptococci and were differentiated from the non-Enterococcal group D streptococci such as Streptococcus bovis by distinctive biochemical characteristics [2] . Enterococcus faecalis and Enterococcus faecium are the most prevalent species cultured from humans, accounting for more than 90% of clinical isolates. Other Enterococcal species known to cause human infection include Enterococcus avium, Enterococcus gallinarum, Enterococcus casseliflavus, Enterococcus durans, Enterococcus raffinosus and Enterococcus mundtii. E faecium represents most vancomycin-resistant Enterococci (VRE) [1] . Infections commonly caused by Enterococci include urinary tract infections, endocarditis, bacteremia, catheter-related infections, wound infections and intra-abdominal and pelvic infections. Intestinal colonization with resistant enterococcal strains is more common than clinical infection. Colonized patients are a potential source for the spread of organisms to the health care workers, the environment and other patients [3] . Enterococci can survive for long periods on environmental surfaces, contributing to their transmission. VRE have been isolated from all objects and sites in health care facilities [4] . For colonization development and infection with VRE, antimicrobial and non antimicrobial risk factors have been identified [5] . Third-generation cephalosporins, aminoglycosides, aztreonam, ciprofloxacin, imipenem, clindamycin and metronidazole have been associated with VRE colonization. Non-antimicrobial risk factors (e.g., increased duration of exposure to individuals colonized with VRE and close proximity to other colonized patients) increase the likelihood of VRE exposure [2] . According to recent surveys, Enterococci remain in the top 3 most common pathogens that cause nosocomial infections. Nosocomial Enterococcal infections typically occur in very ill debilitated patients who have been exposed to broad-spectrum antibiotics. These emphasize the need for their identification from the clinical specimens and also differentiate them from other group D streptococci which are generally more sensitive to the antimicrobial agents. Keeping these in mind the present study has been undertaken in 
Specimens collected
 Urine  Pus  Blood  Endotracheal aspirates  Sputum
Collection and transport of specimen Data collection
Complete data about the patients such as name, age, sex, hospital number, date, time of collection, source of specimen and details about the clinical history was recorded before the specimen was processed. All specimens for microbiological processing were collected in appropriate sterile containers. For urine collection the patients were given a sterile, screw capped, wide mouth, leak proof, labeled with name of the patient and number of the sample on the containers and patients were advised how to collect the midstream urine to avoid contamination. For sputum collection a well coughed out sample was collected in sterile, wide mouthed, screw capped container labeled with name and number of the specimen. Pus, other aspirates were collected in a test tube and pus from the site of lesion like abscesses, boils, infected wounds etc. was collected by using at least two sterile cotton swabs Blood sample was collected carefully by first choosing the vein and then the skin was prepared by disinfecting with 70% alcohol, dried and then 2% of tincture iodine was applied and allowed it to dry. Then the vein was punctured with sterile needle and 5 ml of blood was collected without touching the site. Collected blood sample was then inoculated into blood culture bottles and then transported to the laboratory immediately for the incubation. Endotracheal aspirates were collected by using sterile 12 Gauge endo tracheal suction catheter tube. Suction catheter was connected to the suction pump and passed through endotracheal tube. In case of purulent secretion the endotracheal suction catheter tips were collected using sterile scissors into the sterile container (screw capped). In case of thick or dry secretions with clinical diagnosis of Pneumonia, sterile normal saline is pushed into endotracheal tube and then suction was done for the aspirate. The samples were transported to microbiology laboratory within 15 minutes. Specimens were processed as soon as they were obtained.
Processing of samples
The samples were plated on to Mac Conkeys agar, blood agar, nutrient agar, Pfizer selective media and incubated at 37 0 C for 24 -48 hours. The plates were examined for growth after 24 hours. If growth was observed, colony morphology and Gram stain morphology were studied. If no growth was observed, the plates were further incubated for the next 24 hours. The colonies were further identified by hanging drop preparation and biochemical reactions. The Gram positive and Gram negative organisms were differentiated and identified by a battery of tests as per standard protocols. The Gram negative organisms are excluded and not further processed as the study is on only Enterococci. . 1 ) (6) .
Identification of Enterococci

Fig. 1-
Identification of species
The speciation is done by subjecting the isolates with a battery of biochemical and other tests like sugar fermentation (Glucose, Sucrose, Mannitol, Raffinose, Arabinose and Sorbitol). L-Arginine decarboxylase, Pyruvate fermentation, Motility testing is done and results interpreted ( After inoculum has dried specific antibiotics discs were placed 2 cm apart from each other with sterile forceps and was incubated for 18-24 hours at 37 o C aerobically. The zone size was interpreted according to the reference chart provided by the manufactures, according to NCCLS standards for each organism. The Antibiotic discs used for Gram positive cocci were: Penicillin G (10 units/disc), Erythromycin (15mg/disc), Ciprofloxacin (30mg/disc), Gentamicin (50mg/disc), Nalidixic acid (30mg/disc), Vancomycin (30mg/disc). 
Materials required
Sterile graduated pipettes of 10ml, 5ml, 2ml and 1ml. Sterile capped 7.5 x 1.3 cm tubes, Pasteur pipettes, overnight broth culture of test and control organisms (same as for disc diffusion tests), Vancomycin antibiotic in powder form is obtained from the Hi-Media manufacturer accompanied by a statement of its activity in mg/ per ml solvent for the antibiotic, sterile Distilled Water and nutrient broth medium for testing the isolate.
Preparation of stock solutions
Stock solutions were prepared using the formula (1000/P) X V X C=W, where P = potency of the antibiotic base, V=volume in ml required, C=final concentration of solution and W=weight of the antimicrobial to be dissolved in V.
Medium used for broth and Agar dilution
Brain heart infusion broth is used for testing the isolates by broth dilution. 5ml of broth is added after sterilization to sterile test tubes. Mueller Hinton Agar is used for agar dilution testing.
Preparation of broth and agar dilutions Stock solution
Stock solution can be prepared using the formula 1000 ---x V x C= W P Where P=Potency given by the manufacturer in relation to the base V= Volume in ml required C=Final concentration of solution (multiples of 1000) W= Weight of the antimicrobial to be dissolved in the volume V. Preparation of stock solutions and various concentrations of dilutions for both tube dilution and agar dilution are mentioned below. Stock solution -III (100mg/ml)-0.1 ml of stock solution-I is transferred to 9.9 ml of distilled water (stock solution-III) which gives a concentration of 100mg/ml.
ANNEXURE -I
Preparation of various drug concentration for tube dilutionInoculum preparation
At least three to five well-isolated colonies of the same morphological type are selected from an agar plate culture. The top of each colony is touched with a loop and the growth is transferred into a tube containing 4 to 5 ml of a Nutrient broth medium. The broth culture is incubated at 37°C until it achieves or exceeds the turbidity of the 0.5 McFarland standard 2 -6 hours. The turbidity of the actively growing broth culture is adjusted with sterile saline or broth to obtain turbidity optically comparable to that of the 0.5 McFarland standards. Finally suspension containing approximately 1 x 10 6 CFU/ml for Enterococci ATCC 29212, isolates is compared with 0.5 McFarland standards in adequate light with a white background and contrasting black lines. Procedure 1-2 µl of inoculum is transferred to the agar plates which give a final concentration f 10 4 cfu/ml, similarly 0.1ml of inoculum. is aseptically transferred to each of the different concentration test tubes. A control tube and an agar plate also inoculated which does not have the antibiotics. The plates and tubes are incubated at 37°c for 24 hours along with controls.
Reading of result
MIC is expressed as the lowest dilution, which inhibits the growth which is judged by lack of turbidity in the tube. Because very faint turbidity may be given by the inoculum itself, the inoculated tube kept in the refrigerator overnight may be used as the standard for the determination of complete inhibition. Standard strain of known MIC value Enterococci ATCC 29212, also run along with the test to check the reagents and conditions. The results were recorded in a standard chart for both broth and tube dilution and interpreted.
Quality control of media and other tests
Each batch of medium was tested for sterility by selecting a plate at random and incubated at 37°c for 24-48 hours. Further the plates were inoculated with the positive and negative control organisms to know the performance of the media.
Results
A total of 928 samples were collected from both out and in patients. Among these 647(69.72%) were culture positive and 281 (30.28) were culture negative ( Table-1 ). Gender wise distribution of samples were, males 511(55.06%) and females 417(44.94%) ( Table-2 ). Age wise distribution of samples, the youngest patient was 1 year and oldest was 80 years old (Table-3 ). Distribution of different types of samples like Urine, Pus, ET-aspirates and Blood etc ( Table-4 ). Prevalence of Enterococci and other isolates in the total number 647 of positive samples; Enterococci were 100 (15.46%) ( Table-5 ). Prevalence of Enterococci among different samples Enterococci was isolated more from urine sample 59% (Table-6 ). All 100 isolates of Enterococci were identified as Enterococcus faecalis (Table-7 ).
Antimicrobial resistance of Enterococcus faecalis isolates (100) by disk diffusion method by battery of antibiotic (Table-8 ). Among all the isolates (100), one isolate showed MIC of 34µg/ml in both macrodilution (Table-9 & Fig. 4 ) and agar dilution methods ( Table  -10 One strain showed Vancomycin resistance in our study with 1% and 15% intermediate resistance in our present study which is also reported by other Indian studies (9) . In contrast to reports from U.S.A where Vancomycin resistance is more common. In our study, about 12 of Enterococcal strains showed raised MIC of 8 µg/ml.
Conclusion
Precise identification of Enterococci to species level enables us, to assess the species-specific antimicrobial resistance characteristics, apart from knowing the epidemiological pattern and their clinical significance in human infections. Further as shown in our study, the increase in the rate of prevalence of the Enterococcus species and the emergence of multidrug resistance among them, highlights the significance of rapid and accurate identification of Enterococci to the species level for initiating appropriate therapeutic regimen and reemphasize the importance of the implementation of appropriate infection control measures to limit the nosocomial spread of these Enterococci species in any nosocomial setting. Vancomycin in combination with an aminoglycoside has synergistic activity against enterococci and is recommended as the drug of choice in patients with ampicillin-and penicillin-resistant. However, enterococci are becoming increasingly resistant to traditional antibiotic therapy. In addition to high-level aminoglycoside resistance and ampicillin resistance, rapid spread of vancomycin resistance has resulted in limited therapeutic alternatives. Important to maintain regular surveillance of antibiotic susceptibilities so that changes in their pattern can be detected early.
As MIC detection is a laborious procedure all Enterococcal isolates can be screened by vancomycin agar screen method containing 6µg/ml which is suggested by NCCLS and only those isolates which are positive by this method can be tested further for vancomycin MIC, as both the methods correlated well in this study.
Effective detection of vancomycin resistance in laboratory helps in reducing the morbidity and mortality due to VRE in hospitalized patients.
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